Loss of ACBD3 is lethal in mice, and ACBD3 is upregulated in multiple breast cancers in which high ACBD3 expression correlates with poor patient survival (Huang et al., 2018; Houghton-Gisby and J. Harvey, 2020). Here, ACBD3 is linked to breast cancer.